EXEL INDUSTRIES SA-A SHS (EXE.PA) Fundamental Analysis & Valuation

EPA:EXE • FR0004527638

Current stock price

31.9 EUR
+0.1 (+0.31%)
Last:

This EXE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. EXE.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EXE was profitable.
  • EXE had a positive operating cash flow in the past year.
  • In the past 5 years EXE has always been profitable.
  • Of the past 5 years EXE 4 years had a positive operating cash flow.
EXE.PA Yearly Net Income VS EBIT VS OCF VS FCFEXE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

  • With a Return On Assets value of 1.93%, EXE perfoms like the industry average, outperforming 43.52% of the companies in the same industry.
  • EXE has a Return On Equity of 3.49%. This is in the lower half of the industry: EXE underperforms 61.11% of its industry peers.
  • EXE has a Return On Invested Capital (4.79%) which is comparable to the rest of the industry.
  • EXE had an Average Return On Invested Capital over the past 3 years of 6.85%. This is in line with the industry average of 8.73%.
Industry RankSector Rank
ROA 1.93%
ROE 3.49%
ROIC 4.79%
ROA(3y)3.41%
ROA(5y)3.8%
ROE(3y)6.6%
ROE(5y)7.55%
ROIC(3y)6.85%
ROIC(5y)6.77%
EXE.PA Yearly ROA, ROE, ROICEXE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • With a Profit Margin value of 1.65%, EXE is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of EXE has declined.
  • EXE has a worse Operating Margin (3.80%) than 65.74% of its industry peers.
  • EXE's Operating Margin has declined in the last couple of years.
  • EXE has a better Gross Margin (48.37%) than 64.81% of its industry peers.
  • EXE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.8%
PM (TTM) 1.65%
GM 48.37%
OM growth 3Y-0.11%
OM growth 5Y-4.11%
PM growth 3Y-17.34%
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y7.45%
EXE.PA Yearly Profit, Operating, Gross MarginsEXE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

5

2. EXE.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EXE is creating some value.
  • Compared to 1 year ago, EXE has about the same amount of shares outstanding.
  • Compared to 5 years ago, EXE has about the same amount of shares outstanding.
  • EXE has a better debt/assets ratio than last year.
EXE.PA Yearly Shares OutstandingEXE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
EXE.PA Yearly Total Debt VS Total AssetsEXE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 2.76 indicates that EXE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • EXE has a better Altman-Z score (2.76) than 60.19% of its industry peers.
  • EXE has a debt to FCF ratio of 3.06. This is a good value and a sign of high solvency as EXE would need 3.06 years to pay back of all of its debts.
  • The Debt to FCF ratio of EXE (3.06) is better than 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.13 indicates that EXE is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.13, EXE is doing good in the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 3.06
Altman-Z 2.76
ROIC/WACC0.71
WACC6.73%
EXE.PA Yearly LT Debt VS Equity VS FCFEXE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.84 indicates that EXE should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.84, EXE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • EXE has a Quick Ratio of 1.84. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.87, EXE is doing worse than 61.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 0.87
EXE.PA Yearly Current Assets VS Current LiabilitesEXE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2

3. EXE.PA Growth Analysis

3.1 Past

  • The earnings per share for EXE have decreased strongly by -47.83% in the last year.
  • EXE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.02% yearly.
  • Looking at the last year, EXE shows a very negative growth in Revenue. The Revenue has decreased by -10.58% in the last year.
  • The Revenue has been growing slightly by 5.44% on average over the past years.
EPS 1Y (TTM)-47.83%
EPS 3Y-17.02%
EPS 5YN/A
EPS Q2Q%-38.37%
Revenue 1Y (TTM)-10.58%
Revenue growth 3Y0.2%
Revenue growth 5Y5.44%
Sales Q2Q%-11.03%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.94% on average over the next years. This is quite good.
  • Based on estimates for the next years, EXE will show a decrease in Revenue. The Revenue will decrease by -2.59% on average per year.
EPS Next Y21.41%
EPS Next 2Y18.29%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue Next Year-2.27%
Revenue Next 2Y0.61%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXE.PA Yearly Revenue VS EstimatesEXE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
EXE.PA Yearly EPS VS EstimatesEXE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

8

4. EXE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.29, the valuation of EXE can be described as correct.
  • 82.41% of the companies in the same industry are more expensive than EXE, based on the Price/Earnings ratio.
  • EXE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.38.
  • With a Price/Forward Earnings ratio of 9.41, the valuation of EXE can be described as very reasonable.
  • EXE's Price/Forward Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 91.67% of the companies in the same industry.
  • EXE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.20.
Industry RankSector Rank
PE 13.29
Fwd PE 9.41
EXE.PA Price Earnings VS Forward Price EarningsEXE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EXE is valued cheaper than 87.04% of the companies in the same industry.
  • 91.67% of the companies in the same industry are more expensive than EXE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.72
EV/EBITDA 4.59
EXE.PA Per share dataEXE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • EXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EXE's earnings are expected to grow with 18.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y18.29%
EPS Next 3Y18.94%

3

5. EXE.PA Dividend Analysis

5.1 Amount

  • EXE has a Yearly Dividend Yield of 1.85%. Purely for dividend investing, there may be better candidates out there.
  • EXE's Dividend Yield is a higher than the industry average which is at 1.58.
  • EXE's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EXE.PA Yearly Dividends per shareEXE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 48.10% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
DP48.1%
EPS Next 2Y18.29%
EPS Next 3Y18.94%
EXE.PA Yearly Income VS Free CF VS DividendEXE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M
EXE.PA Dividend Payout.EXE.PA Dividend Payout, showing the Payout Ratio.EXE.PA Dividend Payout.PayoutRetained Earnings

EXE.PA Fundamentals: All Metrics, Ratios and Statistics

EXEL INDUSTRIES SA-A SHS

EPA:EXE (4/16/2026, 1:16:05 PM)

31.9

+0.1 (+0.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-28
Earnings (Next)05-22
Inst Owners6.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap216.60M
Revenue(TTM)983.01M
Net Income(TTM)16.24M
Analysts48.89
Price Target38.76 (21.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend1.15
Dividend Growth(5Y)N/A
DP48.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.05%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.66%
Revenue NY rev (3m)-4.5%
Valuation
Industry RankSector Rank
PE 13.29
Fwd PE 9.41
P/S 0.22
P/FCF 4.72
P/OCF 3.06
P/B 0.46
P/tB 0.57
EV/EBITDA 4.59
EPS(TTM)2.4
EY7.52%
EPS(NY)3.39
Fwd EY10.62%
FCF(TTM)6.76
FCFY21.2%
OCF(TTM)10.43
OCFY32.68%
SpS144.77
BVpS68.62
TBVpS55.83
PEG (NY)0.62
PEG (5Y)N/A
Graham Number60.871 (90.82%)
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 3.49%
ROCE 6.65%
ROIC 4.79%
ROICexc 5.17%
ROICexgc 6.21%
OM 3.8%
PM (TTM) 1.65%
GM 48.37%
FCFM 4.67%
ROA(3y)3.41%
ROA(5y)3.8%
ROE(3y)6.6%
ROE(5y)7.55%
ROIC(3y)6.85%
ROIC(5y)6.77%
ROICexc(3y)7.59%
ROICexc(5y)7.7%
ROICexgc(3y)9.29%
ROICexgc(5y)9.68%
ROCE(3y)9.53%
ROCE(5y)9.41%
ROICexgc growth 3Y-4.12%
ROICexgc growth 5Y-5.56%
ROICexc growth 3Y-2.57%
ROICexc growth 5Y-3.96%
OM growth 3Y-0.11%
OM growth 5Y-4.11%
PM growth 3Y-17.34%
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y7.45%
F-Score7
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 3.06
Debt/EBITDA 0.92
Cap/Depr 79.73%
Cap/Sales 2.53%
Interest Coverage 5.82
Cash Conversion 103.29%
Profit Quality 282.72%
Current Ratio 1.84
Quick Ratio 0.87
Altman-Z 2.76
F-Score7
WACC6.73%
ROIC/WACC0.71
Cap/Depr(3y)84.53%
Cap/Depr(5y)85.26%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.34%
Profit Quality(3y)163.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.83%
EPS 3Y-17.02%
EPS 5YN/A
EPS Q2Q%-38.37%
EPS Next Y21.41%
EPS Next 2Y18.29%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.58%
Revenue growth 3Y0.2%
Revenue growth 5Y5.44%
Sales Q2Q%-11.03%
Revenue Next Year-2.27%
Revenue Next 2Y0.61%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A
EBIT growth 1Y-33.86%
EBIT growth 3Y0.09%
EBIT growth 5Y1.1%
EBIT Next Year105.8%
EBIT Next 3Y31.99%
EBIT Next 5YN/A
FCF growth 1Y137.81%
FCF growth 3YN/A
FCF growth 5Y1.4%
OCF growth 1Y42.89%
OCF growth 3YN/A
OCF growth 5Y5.62%

EXEL INDUSTRIES SA-A SHS / EXE.PA Fundamental Analysis FAQ

What is the fundamental rating for EXE stock?

ChartMill assigns a fundamental rating of 4 / 10 to EXE.PA.


What is the valuation status for EXE stock?

ChartMill assigns a valuation rating of 8 / 10 to EXEL INDUSTRIES SA-A SHS (EXE.PA). This can be considered as Undervalued.


How profitable is EXEL INDUSTRIES SA-A SHS (EXE.PA) stock?

EXEL INDUSTRIES SA-A SHS (EXE.PA) has a profitability rating of 4 / 10.


What is the valuation of EXEL INDUSTRIES SA-A SHS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EXEL INDUSTRIES SA-A SHS (EXE.PA) is 13.29 and the Price/Book (PB) ratio is 0.46.


How financially healthy is EXEL INDUSTRIES SA-A SHS?

The financial health rating of EXEL INDUSTRIES SA-A SHS (EXE.PA) is 5 / 10.